Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib in Subjects With Unresectable Hepatocellular Carcinoma (uHCC)
Clinical trial NCT03433703 · TERMINATED
Trial details
- NCT number
- NCT03433703
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2019-01-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.